Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-07
2006-11-07
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S350000, C530S395000
Reexamination Certificate
active
07132395
ABSTRACT:
Method of inhibiting human rhinovirus (HRV) Infection by contacting said HRV with a polypeptide comprising a fragment of human rhinovirus major receptor (HRR), said fragment comprising the HRV binding site and being selected from a specific group consisting of HRR domains.
REFERENCES:
patent: 4171365 (1979-10-01), Diana et al.
patent: 4209526 (1980-06-01), Diana et al.
patent: 4232161 (1980-11-01), Diana et al.
patent: 4234725 (1980-11-01), Diana et al.
patent: 4261928 (1981-04-01), Diana et al.
patent: 4372976 (1983-02-01), Diana
patent: 4427653 (1984-01-01), Springer
patent: 4451476 (1984-05-01), Diana
patent: 4843087 (1989-06-01), Diana
patent: 4956281 (1990-09-01), Wallner et al.
patent: 5081228 (1992-01-01), Dower et al.
patent: 5109123 (1992-04-01), Reinherz et al.
patent: 5179017 (1993-01-01), Axel et al.
patent: 5235049 (1993-08-01), McClelland et al.
patent: 5240694 (1993-08-01), Gwaltney, Jr.
patent: 5284931 (1994-02-01), Springer et al.
patent: 5304636 (1994-04-01), Blaas et al.
patent: 5324510 (1994-06-01), Wegner et al.
patent: 5340800 (1994-08-01), Liu et al.
patent: 5349053 (1994-09-01), Landolfi
patent: 5359046 (1994-10-01), Capon et al.
patent: 5372933 (1994-12-01), Zamarron et al.
patent: 5395929 (1995-03-01), Corbi et al.
patent: 5422097 (1995-06-01), Gwaltney
patent: 5472849 (1995-12-01), Rothlein et al.
patent: 5475091 (1995-12-01), Springer et al.
patent: 5525487 (1996-06-01), Gallatin et al.
patent: 5532127 (1996-07-01), Gallatin et al.
patent: 5580969 (1996-12-01), Hoke et al.
patent: 5589453 (1996-12-01), Greve
patent: 5597567 (1997-01-01), Whitcup et al.
patent: 5603932 (1997-02-01), Blaas et al.
patent: 5612216 (1997-03-01), Springer et al.
patent: 5663293 (1997-09-01), Gallatin et al.
patent: 5674982 (1997-10-01), Greve et al.
patent: 5686581 (1997-11-01), Greve et al.
patent: 5686582 (1997-11-01), Greve et al.
patent: 5712245 (1998-01-01), Blaas et al.
patent: 5730983 (1998-03-01), Wegner et al.
patent: 5821341 (1998-10-01), McClelland et al.
patent: 5831036 (1998-11-01), Springer et al.
patent: 5849699 (1998-12-01), McClelland et al.
patent: 5859212 (1999-01-01), McClelland et al.
patent: 5871733 (1999-02-01), Greve et al.
patent: 5879712 (1999-03-01), Bomberger et al.
patent: 6051231 (2000-04-01), Greve
patent: 6096862 (2000-08-01), Greve et al.
patent: 6107461 (2000-08-01), Greve et al.
patent: 6130202 (2000-10-01), Greve et al.
patent: 6143298 (2000-11-01), Greve et al.
patent: 6514936 (2003-02-01), Greve et al.
patent: A-14630/88 (1988-10-01), None
patent: 1551888 (1988-11-01), None
patent: 2633288 (1989-05-01), None
patent: 623105 (1989-06-01), None
patent: B-48767/90 (1990-02-01), None
patent: 637324 (1990-03-01), None
patent: 5129990 (1990-09-01), None
patent: 623105 (1992-05-01), None
patent: 637324 (1993-05-01), None
patent: 641134 (1993-09-01), None
patent: 652567 (1994-09-01), None
patent: 675441 (1997-02-01), None
patent: 1339193 (1997-08-01), None
patent: 3712678 (1988-10-01), None
patent: 0169146 (1986-01-01), None
patent: 0169146 (1986-01-01), None
patent: 0169729 (1986-01-01), None
patent: 0192175 (1986-08-01), None
patent: 0207453 (1987-01-01), None
patent: 0227604 (1987-07-01), None
patent: 0261403 (1988-03-01), None
patent: 0280578 (1988-08-01), None
patent: 0287076 (1988-10-01), None
patent: 0289949 (1988-11-01), None
patent: 0289949 (1988-11-01), None
patent: 0314863 (1989-05-01), None
patent: 0319815 (1989-06-01), None
patent: 0319815 (1989-06-01), None
patent: 0380068 (1990-01-01), None
patent: 0362526 (1990-04-01), None
patent: 0362531 (1990-04-01), None
patent: 0365837 (1990-05-01), None
patent: 0379904 (1990-08-01), None
patent: 0387701 (1990-09-01), None
patent: 0391088 (1990-10-01), None
patent: 0459577 (1991-12-01), None
patent: 0468257 (1992-01-01), None
patent: 0510483 (1992-10-01), None
patent: 0566554 (1993-10-01), None
patent: 0319815 (1994-08-01), None
patent: 0379904 (1996-05-01), None
patent: 0287076 (1998-10-01), None
patent: 0488061 (1998-11-01), None
patent: 100601 (1998-01-01), None
patent: 2022826 (1979-12-01), None
patent: 74144 (1997-07-01), None
patent: 91454 (1995-08-01), None
patent: 202435 (1999-06-01), None
patent: 230474 (1989-08-01), None
patent: 232203 (1990-01-01), None
patent: 92920 (1990-07-01), None
patent: 91570 (1994-11-01), None
patent: 90/0469 (1990-10-01), None
patent: 52785 (1991-11-01), None
patent: 52785 (1992-03-01), None
patent: WO 88/06592 (1988-09-01), None
patent: WO 89/10938 (1989-11-01), None
patent: 0364690 (1990-04-01), None
patent: WO 90/03400 (1990-04-01), None
patent: 0387668 (1990-09-01), None
patent: WO 90/10646 (1990-09-01), None
patent: WO 90/10652 (1990-09-01), None
patent: WO 90/13316 (1990-11-01), None
patent: WO 91/16927 (1991-11-01), None
patent: WO 91/16928 (1991-11-01), None
patent: WO 91/18010 (1991-11-01), None
patent: WO 91/18011 (1991-11-01), None
patent: 9201049 (1992-01-01), None
patent: 9206119 (1992-04-01), None
patent: 9212994 (1992-08-01), None
patent: 9306842 (1993-04-01), None
patent: 9306850 (1993-04-01), None
patent: 9313210 (1993-07-01), None
patent: 9400485 (1994-01-01), None
patent: 9401553 (1994-01-01), None
patent: 9411400 (1994-05-01), None
patent: 9527736 (1995-10-01), None
patent: 9528170 (1995-10-01), None
patent: 9603142 (1996-02-01), None
patent: 9606622 (1996-03-01), None
patent: 9627292 (1996-09-01), None
patent: 9634015 (1996-10-01), None
patent: 9640069 (1996-12-01), None
patent: 896668 (1990-06-01), None
patent: 900469 (1990-10-01), None
Rothlein, R. et al. J. Immunol 137: 1270-1274. Aug. 15, 1986. A human intercellular adhesion molecule, (ICAM-1). . .
Tomassini, J.E. et al. J. Virol. 58(2) 290-295. May 1986 Isolation of a receptor protein . . .
Ruoslahti, E. et al. in Synthetic Peptides in Biol. and Medicine, Alitalo, K. et al (ed.), 1985 Elsevier, N.Y.
Dustin, M. L. et al. J. Immunol. 137(1):245-254. Jul. 1, 1986 Induction by IL-1 . . .
Marlin, S. D. et al. Cell 51:813-819. Dec. 4, 1987. Purified Intercell. Adhes. Mol.-1 (ICAM-1) is a ligand. . .
Abraham, G. and R.J. Colonno, “Many Rhinovirus Serotypes Share the Same Cellular Receptor”, J. Virol. 51:340-345.
Colonno, R.J. and J.E. Tomassini, “Viral Receptors: A Novel Approach for the Prevention of Human Rhinovirus Infection”, inMedical Virology VI, de la Maza, L.M. and E.M. Peterson, eds. (Elsevier, New York, 1987), pp. 331-351.
Colonno, R.J., P.L. Callahan, and W.J. Long, “Isolation of a Monoclonal Antibody That Blocks Attachment of the Major Group of Human Ehinoviruses”, J. Virol. (1986) 57(1):7-12.
Ginsberg, M., M.D. Pierschbacher, E. Ruoslahti, G. Marguerie, and E. Plow, “Inhibition of Fibronectin Binding to Platelets by Proteolytic Fragments and Synthetic Peptides Which Support Fibroblast Adhesion”, J. Biol. Chem. (1985) 260(7):3931-3936.
Medical Microbiology: An Introduction to Infectious Diseases, 2d ed., J.C. Sherris, ed. (Elsevier Science Publishing Co., Inc., NY 1990), pp. 514-515.
Tomassini, J.E. and R.J. Colonno, “Isolation of a Receptor Protein Involved in Attachment of Human Rhinoviruses”, J. Virol. 58(2):290-295.
Winther, B., J.M. Gwaltney, Jr., N. Mygind, R.B. Turner, and J.O. Hendley, “Sites of Rhinovirus Recovery After Point Inoculation of the Upper Airway”, JAMA (1986) 256(13):1763-1767.
Hsiung, G.D., Chapter 14 “Picornaviridae”, inHsiung Diagnostic Virology, Fourth Edition, Hsiung, G. D., C. K. Y. Fong, and M. L. Landry, eds., (Yale University Press, New Haven , 1994), pp. 119-140.
Abraham, G. and R.J. Colonno, “Characterization of human rhinoviruses displaced by an anti-receptor monoclonal antibody”, J. Virol.62(7):2300-2306 (Jul. 1988).
Ashkenazi, A., L.G. Presta, S.A. Marsters, T.R. Camerato, K.A. Rosen, B.M. Fendly, and D.J. Capon, “Mapping the CD4 binding site for human immunodeficiency virus by alanine scanning mutagenesis”, Proc. Natl. Acad. Sci. USA 87:7150-7154 (Sep. 1990).
Brodsky, M.H., M.Warton, R.M. Myers, and D.R. Littman, “Analysis of the site in CD4 that binds to the HIV envelope glycoprotein”, J. Immunol.
Davis Gary
Greve Jeffrey M.
McClelland Alan
Bayer Pharmaceuticals Corporation
Gambel Phillip
Shimei Barbara A.
LandOfFree
Antiviral methods using human rhinovirus receptor (ICAM-1) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral methods using human rhinovirus receptor (ICAM-1), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral methods using human rhinovirus receptor (ICAM-1) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3624287